Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study

INTRODUCTION: As the immunosuppressive potency of 15-deoxyspergualin (DSG) has been shown in the therapy of renal transplant rejection and Wegener's granulomatosis, the intention of this study was to evaluate the safety of DSG in the therapy of lupus nephritis (LN). METHODS: Patients with histo...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Lorenz, Hanns-Martin, Schmitt, Wilhelm H, Tesar, Vladimir, Müller-Ladner, Ulf, Tarner, Ingo, Hauser, Ingeborg A, Hiepe, Falk, Alexander, Tobias, Woehling, Heike, Nemoto, Kyuichi, Heinzel, Peter A
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2011
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3132014/
https://ncbi.nlm.nih.gov/pubmed/21356124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3268
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन